{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:51:52Z","timestamp":1793224312329,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.autrev.2021.102977","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T01:08:20Z","timestamp":1635383300000},"page":"102977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanisms"],"prefix":"10.1016","volume":"20","author":[{"given":"Andrea","family":"Angeletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pratesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Candiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Prunotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Verrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102977_bb0005","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/PL00000910","article-title":"Multifunctional alpha-enolase: its role in diseases","volume":"58","author":"Pancholi","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2021.102977_bb0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1432-1033.1995.tb20403.x","article-title":"The role of an enolase-related molecule in plasminogen binding to cells","volume":"227","author":"Redlitz","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.autrev.2021.102977_bb0015","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1074\/jbc.275.8.5958","article-title":"Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene","volume":"275","author":"Subramanian","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102977_bb0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1146\/annurev.bi.61.070192.004113","article-title":"Myc function and regulation","volume":"61","author":"Marcu","year":"1992","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.autrev.2021.102977_bb0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(82)91748-2","article-title":"Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer","volume":"1","author":"Carney","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102977_bb0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/bjc.1988.312","article-title":"The value of tumour markers in lung cancer","volume":"58","author":"Gomm","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/j.autrev.2021.102977_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-8981(82)90056-0","article-title":"High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma","volume":"121","author":"Ishiguro","year":"1982","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2021.102977_bb0040","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102977_bb0045","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ygeno.2004.08.010","article-title":"Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes","volume":"84","author":"Altenberg","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.autrev.2021.102977_bb0050","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1158\/1078-0432.CCR-06-0324","article-title":"Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes","volume":"12","author":"Chang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.autrev.2021.102977_bb0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-009-0492-0","article-title":"Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells","volume":"121","author":"Tu","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.autrev.2021.102977_bb0060","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.ejca.2010.03.018","article-title":"ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction","volume":"46","author":"Tsai","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.autrev.2021.102977_bb0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.autrev.2006.10.004","article-title":"Alpha-enolase: a target of antibodies in infectious and autoimmune diseases","volume":"6","author":"Terrier","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102977_bb0070","first-page":"1","article-title":"Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis","volume":"7","author":"Bruschi","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102977_bb0075","first-page":"109","article-title":"Autoantibodies specific for alpha-enolase in systemic autoimmune disorders","volume":"27","author":"Pratesi","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102977_bb0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fimmu.2016.00485","article-title":"NETosis as source of autoantigens in rheumatoid arthritis","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2021.102977_bb0085","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1093\/rheumatology\/keaa793","article-title":"Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study","volume":"60","author":"Bruschi","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102977_bb0090","doi-asserted-by":"crossref","first-page":"30591","DOI":"10.1074\/jbc.272.49.30591","article-title":"Understanding enzyme superfamilies. Chemistry as the fundamental determinant in the evolution of new catalytic activities","volume":"272","author":"Babbitt","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102977_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(00)01494-0","article-title":"ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1)","volume":"473","author":"Feo","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2021.102977_bb0100","doi-asserted-by":"crossref","first-page":"156795","DOI":"10.1155\/2012\/156795","article-title":"alpha-Enolase, a multifunctional protein: its role on pathophysiological situations","volume":"2012","author":"Diaz-Ramos","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.autrev.2021.102977_bb0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajh.10299","article-title":"Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-enolase","volume":"72","author":"Lopez-Alemany","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2021.102977_bb0110","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood.V93.11.3839","article-title":"Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)","volume":"93","author":"Longstaff","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102977_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.176.2.415","article-title":"A major surface protein on group a streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity","volume":"176","author":"Pancholi","year":"1992","journal-title":"J Exp Med"},{"issue":"Pt 2","key":"10.1016\/j.autrev.2021.102977_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1099\/00221287-143-2-321","article-title":"3-phosphoglycerate kinase: a glycolytic enzyme protein present in the cell wall of Candida albicans","volume":"143","author":"Alloush","year":"1997","journal-title":"Microbiology"},{"key":"10.1016\/j.autrev.2021.102977_bb0125","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1074\/jbc.273.23.14503","article-title":"alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci","volume":"273","author":"Pancholi","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102977_bb0130","doi-asserted-by":"crossref","first-page":"30861","DOI":"10.1074\/jbc.M110.153825","article-title":"Streptococcus pyogenes Ser\/Thr kinase-regulated cell wall hydrolase is a cell division plane-recognizing and chain-forming virulence factor","volume":"285","author":"Pancholi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102977_bb0135","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1086\/317604","article-title":"Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae","volume":"182","author":"Fontan","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2021.102977_bb0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102977_bb0145","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.23618","article-title":"Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis","volume":"58","author":"Kinloch","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102977_bb0150","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102977_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","article-title":"Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis","volume":"233","author":"Wegner","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2021.102977_bb0160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2021.102977_bb0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","article-title":"Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Catrina","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102977_bb0170","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","article-title":"Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase","volume":"58","author":"Lundberg","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102977_bb0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.1101400","article-title":"Human PAD4 regulates histone arginine methylation levels via demethylimination","volume":"306","author":"Wang","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102977_bb0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fimmu.2012.00307","article-title":"PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures","volume":"3","author":"Leshner","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102977_bb0185","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102977_bb0190","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1083\/jcb.201203170","article-title":"Neutrophil extracellular traps: is immunity the second function of chromatin?","volume":"198","author":"Brinkmann","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2021.102977_bb0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2009.07.011","article-title":"NETs: a new strategy for using old weapons","volume":"30","author":"Papayannopoulos","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2021.102977_bb0200","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","article-title":"Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps","volume":"73","author":"Pratesi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102977_bb0205","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/IAI.67.7.3248-3256.1999","article-title":"Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase","volume":"67","author":"McGraw","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2021.102977_bb0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10753-004-6641-z","article-title":"Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis","volume":"28","author":"Rosenstein","year":"2004","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2021.102977_bb0215","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrrheum.2010.139","article-title":"Periodontitis in RA-the citrullinated enolase connection","volume":"6","author":"Lundberg","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102977_bb0220","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1681\/ASN.2014050493","article-title":"Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): planted antigens","volume":"26","author":"Bruschi","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102977_bb0225","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2015.04.004","article-title":"Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference","volume":"14","author":"Bonanni","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102977_bb0230","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1681\/ASN.2013050446","article-title":"Lupus nephritis susceptibility loci in women with systemic lupus erythematosus","volume":"25","author":"Chung","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102977_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2021.102977_bb0240","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fimmu.2012.00380","article-title":"Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases","volume":"3","author":"Knight","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102977_bb0245","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.2013090987","article-title":"Glomerular autoimmune multicomponents of human lupus nephritis in vivo: alpha-enolase and annexin AI","volume":"25","author":"Bruschi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102977_bb0250","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1038\/s41598-019-44379-w","article-title":"Neutrophil extracellular traps protein composition is specific for patients with lupus nephritis and includes methyl-oxidized alphaenolase (methionine sulfoxide 93)","volume":"9","author":"Bruschi","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.autrev.2021.102977_bb0255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3899\/jrheum.181232","article-title":"Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis","volume":"47","author":"Bruschi","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102977_bb0260","doi-asserted-by":"crossref","first-page":"635436","DOI":"10.3389\/fmed.2021.635436","article-title":"Neutrophil extracellular traps in systemic lupus erythematosus stimulate IgG2 production from B lymphocytes","volume":"8","author":"Bertelli","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2021.102977_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.102977_bb0270","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.102977_bb0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2021.102977_bb0280","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New \u2018Antigens\u2019 in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102977_bb0285","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"2020","key":"10.1016\/j.autrev.2021.102977_bb0290","article-title":"N. Italian study Group for Membranous, multi-autoantibody signature and clinical outcome in membranous nephropathy","volume":"15","author":"Ghiggeri","year":"1762","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102977_bb0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/ndt\/gfn453","article-title":"Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis","volume":"24","author":"Fang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2021.102977_bb0300","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2215\/CJN.04800511","article-title":"Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis","volume":"7","author":"Song","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102977_bb0305","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jprot.2011.05.021","article-title":"Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens","volume":"74","author":"Bruschi","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.autrev.2021.102977_bb0310","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1742-4658.2011.08025.x","article-title":"Alpha-enolase: a promising therapeutic and diagnostic tumor target","volume":"278","author":"Capello","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.autrev.2021.102977_bb0315","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0896-8411(95)80027-1","article-title":"Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis","volume":"8","author":"Walter","year":"1995","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102977_bb0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/pr100213b","article-title":"Circulating autoantibodies to phosphorylated alpha-enolase are a hallmark of pancreatic cancer","volume":"10","author":"Tomaino","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.autrev.2021.102977_bb0325","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1158\/0008-5472.CAN-04-3262","article-title":"Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry","volume":"64","author":"Shen","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2021.102977_bb0330","article-title":"Proteome serological determination of tumor-associated antigens in melanoma","volume":"4","author":"Forgber","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102977_bb0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-007-9721-6","article-title":"Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy","volume":"110","author":"Ejma","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.autrev.2021.102977_bb0340","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1349-7006.2007.00509.x","article-title":"Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer","volume":"98","author":"He","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.autrev.2021.102977_bb0345","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pmic.200500256","article-title":"Proteome analysis of human lung squamous carcinoma","volume":"6","author":"Li","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.autrev.2021.102977_bb0350","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/prca.200700206","article-title":"Tumor antigens eliciting autoantibody response in cancer of gingivo-buccal complex","volume":"1","author":"Shukla","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.autrev.2021.102977_bb0355","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1074\/mcp.M400165-MCP200","article-title":"Proteomics-based identification of human acute leukemia antigens that induce humoral immune response","volume":"4","author":"Cui","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.autrev.2021.102977_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2015.06.008","article-title":"Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation","volume":"167","author":"Capello","year":"2015","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2021.102977_bb0365","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/jaut.1998.0239","article-title":"Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells","volume":"11","author":"Adamus","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102977_bb0370","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/jaut.1998.0221","article-title":"Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo","volume":"11","author":"Adamus","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102977_bb0375","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.vaccine.2004.01.042","article-title":"Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase a, and putative proteinase maturation protein a in relation to pneumococcal carriage and otitis media","volume":"22","author":"Adrian","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2021.102977_bb0380","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/jcm.32.1.17-23.1994","article-title":"Diagnostic value of anti-Candida enolase antibodies","volume":"32","author":"van Deventer","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.autrev.2021.102977_bb0385","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/iai.60.4.1550-1557.1992","article-title":"Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera","volume":"60","author":"Ishiguro","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2021.102977_bb0390","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2005.10.014","article-title":"Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease","volume":"172","author":"Dale","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2021.102977_bb0395","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(66)92876-5","article-title":"Hashimoto's disease and encephalopathy","volume":"2","author":"Brain","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102977_bb0400","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00900946","article-title":"Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment","volume":"243","author":"Kothbauer-Margreiter","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2021.102977_bb0405","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.41.2_Part_1.228","article-title":"Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases","volume":"41","author":"Shaw","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102977_bb0410","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jneuroim.2005.02.004","article-title":"Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy","volume":"162","author":"Fujii","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2021.102977_bb0415","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(02)03307-0","article-title":"Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy","volume":"528","author":"Ochi","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2021.102977_bb0420","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/73200","article-title":"In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope","volume":"6","author":"Anderson","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.102977_bb0425","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.102977_bb0430","first-page":"28","article-title":"Anti-alpha-enolase antibodies in Behcet's disease: a marker of mucocutaneous and articular disease activity?","volume":"36","author":"Prado","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102977_bb0435","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fimmu.2017.00505","article-title":"Impact of autoantibodies against glycolytic enzymes on pathogenicity of autoimmune retinopathy and other autoimmune disorders","volume":"8","author":"Adamus","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102977_bb0440","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/JLB.3A0620-128R","article-title":"Enolase-specific cross antibodies induce neutrophilic inflammation in the intestine","volume":"109","author":"Lin","year":"2021","journal-title":"J Leukoc Biol"},{"issue":"Suppl. 125","key":"10.1016\/j.autrev.2021.102977_bb0445","first-page":"115","article-title":"Fingerprinting of anti-alpha enolase antibodies in systemic sclerosis","volume":"38","author":"Perconti","year":"2020","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:24:39Z","timestamp":1761600279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1568997221002573"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102977","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102977"}}